NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email The UK had its busiest month of the year so far in July for large-scale BESS project planning consent, with over 10GWh approved.Read More
